Abstract

This work explores the first use of UV imaging in liquisolid systems. The aim of this study was to simultaneously measure a model drug propranolol hydrochloride (PPN) release and compact swelling behaviour from liquisolid systems using sesamum radiatum gum by exploiting the visible and UV imaging capabilities of the novel surface dissolution instrument (SDI2). Liquisolid compacts were successfully prepared using polysorbate 80 as the liquid solvent. The influence of either colloidal silica or veegum (magnesium aluminium silicate) was also evaluated in the liquisolid sesamum gum compacts. Solid-state characterization using differential scanning calorimetry (DSC) and X-ray powder diffraction (XRPD) showed a decrease in the crystallinity of the model cationic drug. Visible and UV imaging was successfully used to detect differences between the conventional or physical mixture formulations containing veegum or colloidal silica and the liquisolid preparations as well as differences between their swelling behaviour. The use of this imaging technique provides added insights into the drug release behaviour of formulations.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.